Literature DB >> 26417756

Overlapping phenomena of bipolar disorder and epilepsy--a common pharmacological pathway.

Mariusz S Wiglusz1, Jerzy Landowski, Wiesław J Cubała, Mark Agius.   

Abstract

BACKGROUND: Studies and data on prevalence, recognition and clinical features of bipolar disorder (BD) in epilepsy remain limited. Still, there is a growing evidence of BD and epilepsy being frequent co-morbid conditions with some features suggesting shared pathophysiological mechanisms that include the episodic course of both conditions, the possible kindling mechanism and the efficacy of some antiepileptic drugs (AEDs) in BD. SUBJECTS AND METHODS: The aim of this paper is to review concepts of overlapping phenomena of bipolar disorder and epilepsy. A literature review of the theoretical bases of the relationship between BD and epilepsy is presented.
CONCLUSIONS: The comorbidity of epilepsy and mood disorders was a subject of interest of many studies for decades. Bipolar disorder and epilepsy have a number of clinical, biochemical and pathophysiological features in common. Bipolar disorder in epilepsy, excluding the ictal or periictal symptoms, can be categorized using standardized measures. Standardized psychiatric interview procedures based on DSM criteria like SCID-I or MINI provide comprehensive way to diagnose mood disorders in patients with epilepsy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26417756

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  2 in total

1.  Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.

Authors:  Claudio Toma; Kerrie D Pierce; Alex D Shaw; Anna Heath; Philip B Mitchell; Peter R Schofield; Janice M Fullerton
Journal:  PLoS Genet       Date:  2018-12-26       Impact factor: 5.917

2.  Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort.

Authors:  Christophe G Lambert; Aurélien J Mazurie; Nicolas R Lauve; Nathaniel G Hurwitz; S Stanley Young; Robert L Obenchain; Nicolas W Hengartner; Douglas J Perkins; Mauricio Tohen; Berit Kerner
Journal:  Bipolar Disord       Date:  2016-05       Impact factor: 6.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.